ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- Evergreen Nephrology, a leader in value-based kidney care, today announced it has raised $130...
BYLINE: Enrique Rivero Newswise — People with chronic liver disease can be categorized into four distinct risk groups based on...
Blood Coagulation Analyzers Industry The global blood coagulation analyzers industry is poised for a substantial growth trajectory, according to the...